Signaling Pathways - Inhibitor of apoptosis proteins (IAP) - Protease-Activated Receptors - ErbB - Valosin-containing protein (VCP)
清除全部
- A8815 SM-1648 CitationTarget: Inhibitor of apoptosis proteins (IAP)Summary: 抗癌药
- B1543 Mubritinib (TAK 165)中文名: 木利替尼Target: ErbBSummary: HER2/ErbB2有效抑制剂
- B2168 NMS-8733 CitationTarget: Valosin-containing protein (VCP)Summary: VCP/p97抑制剂
- A8809 Vorapaxar中文名: 沃拉帕沙Target: Protease-Activated ReceptorsSummary: PAR-1拮抗剂
- A8375 AZD8931 (Sapitinib)中文名: 沙普替尼Target: EGFR|ErbBSummary: ErbB抑制剂
- A8319 Dacomitinib (PF299804, PF299)中文名: 达克替尼Target: ErbBSummary: HER抑制剂
- A8229 ML161Target: Protease-Activated ReceptorsSummary: PAR1抑制剂
- A8218 Lapatinib2 Citation中文名: 拉帕替尼Target: ErbBSummary: EGFR/HER2抑制剂
- A3541 LCL1611 CitationTarget: Inhibitor of apoptosis proteins (IAP)Summary: IAPs拮抗剂
- A4224 GDC-01522 CitationTarget: Inhibitor of apoptosis proteins (IAP)Summary: IAP 拮抗剂